US Broker Ratings

Waystar Holding Corp. (WAY): Analyst Consensus Points to 32.64% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is capturing the attention of investors with its promising position in the healthcare sector, specifically within the health information services industry. As a company that..

Telix Pharmaceuticals (TLX): Investor Outlook on a Biotech Powerhouse with 87% Potential Upside

Telix Pharmaceuticals Limited (TLX) is carving a niche in the innovative field of radiopharmaceuticals, with a specific focus on therapeutic and diagnostic solutions. With an impressive market capitalization of $3.84..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Ratings and an 18% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) stands out in the healthcare sector, not just for its extensive portfolio of medical and pharmaceutical distribution services but also for its promising stock performance...

Globus Medical, Inc. (GMED)

⚠️ No article content returned.

..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating Growth, Valuation, and Dividend Potential

Fresenius Medical Care AG (NYSE: FMS), a major player in the healthcare sector specializing in medical care facilities, offers a compelling investment narrative for those interested in the renal care..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 20.60% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in the home and alternate site infusion services industry, presents a compelling case for investors seeking opportunities in the healthcare sector. With..

Genmab A/S (GMAB): Analyst Ratings Signal 16% Upside Potential in Biotech Growth Play

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of antibody-based products aimed at treating cancer and other serious diseases. Headquartered..

Henry Schein, Inc. (HSIC) Stock Report: Analyst Consensus Points to 10.95% Potential Upside

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector with a specific focus on medical distribution, currently commands a market capitalization of $9.86 billion. The company’s stock..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.56% Potential Upside in the Healthcare Sector

Doximity, Inc. (DOCS) stands at the intersection of healthcare and technology, providing a digital platform that connects medical professionals across the United States. With a market capitalization of $4.51 billion,..

Grifols, S.A. (GRFS) Investor Outlook: A Potential 35.81% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, stands out with its robust product lineup and international reach. As a Spanish company specializing in plasma-derived medicines, Grifols..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Challenging Landscape with a Strategic Vision

Avantor, Inc. (AVTR), operating in the dynamic healthcare sector, stands as a formidable player in the medical instruments and supplies industry. With a market capitalization of $9.78 billion, the company..

Corcept Therapeutics (CORT) Stock Analysis: Revenue Growth, Target Price, and Investor Insights

Investors eyeing the healthcare sector, particularly in biotechnology, might find Corcept Therapeutics Incorporated (NASDAQ: CORT) an intriguing prospect. With a market capitalization of $13.22 billion, Corcept is a formidable player..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Strong Buy with a 9.86% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading Italian company in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects in the medical..

Regencell Bioscience Holdings L (RGC): Navigating the Volatility in Healthcare Bioscience

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at an intriguing crossroads, offering both volatility and opportunity in the ever-evolving healthcare sector. As a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience..

Bio-Techne Corp (TECH) Stock Analysis: Insights into the Biotechnology Leader’s Modest Growth and Solid Market Position

Bio-Techne Corp (NASDAQ: TECH), a key player in the biotechnology industry, offers a compelling investment narrative for those seeking exposure to the healthcare sector. With a market capitalization of $11.27..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Complex Landscape with Strategic Partnerships

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Wilmington, Massachusetts, the company has..

Medpace Holdings, Inc. (MEDP): Investor Outlook on Growth and Market Position

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $17.33 billion, the..

Biogen Inc. (BIIB) Stock Analysis: Evaluating a Potential 8.67% Upside in the Healthcare Sector

Biogen Inc. (NASDAQ: BIIB), a leading player in the healthcare sector, particularly within the drug manufacturing industry, offers a compelling investment opportunity with a market capitalization of $32.03 billion. As..

Quest Diagnostics (DGX) Stock Analysis: Navigating a Healthy Growth Path in the Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the Healthcare sector, operates at the forefront of the Diagnostics & Research industry. Headquartered in Secaucus, New Jersey, Quest Diagnostics provides..

Bruker Corporation (BRKR) Stock Analysis: Navigating Market Waves with a 5.20% Revenue Growth in the Healthcare Sector

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors focused on scientific and diagnostic solutions. Founded..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds